Skip to main content

Table 1 Laboratory Tumor Lysis Syndrome criteria

From: Tumor lysis syndrome following trastuzumab and pertuzumab for metastatic breast cancer: a case report

Variable

Value

Change from baseline value

Uric acid

≥8 mg/dL (476 mmol/L)

25 % increase

Potassium

≥6 mEq/L (or 6 mmol/L)

25 % increase

Phosphorus

≥4.5 mg/dL (1.45 mmol/L)

25 % increase

Calcium

≤7 md/dl (1.75 mmol/L)

25 % increase